Incremental value of needle-trajectory radiomics using publicly available three-dimensional transrectal ultrasound data for detecting core-level clinically significant prostate cancer
Eurasian Journal of Medicine and Oncology · 16.11.2026 · 026350451
DOI: 10.36922/ejmo026350451 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 16.11.2026. Verfasst von Yongzhe Zheng und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Transrectal ultrasound (TRUS) radiomics has shown potential for prostate cancer detection, but previous studies have primarily extracted features from lesions or broad anatomical regions. The diagnostic value of ultrasound features surrounding individual biopsy needle trajectories remains unclear.
Objective
To determine whether radiomic features extracted from regions surrounding tracked needle trajectories in three-dimensional (3D) TRUS improve core-level discrimination of clinically significant prostate cancer (csPCa) beyond clinical and anatomical location information.
Methods
We retrospectively analyzed the public Prostate-MRI-US-Biopsy cohort, including 1,129 patients with 17,559 cores. csPCa was defined as a Gleason score of ≥ 7. Cylindrical regions (5-mm radius, with 3-mm and 7-mm sensitivity analyses) were centered on trajectory paths, and 93 PyRadiomics features were extracted. Three L1-penalized logistic regression models (clinical/location baseline, trajectory-radiomics, and combined) were evaluated using nested patient-grouped cross-validation and patient-cluster bootstrap resampling.
Results
After quality control, 16,259 cores (1,561 csPCa) were analyzed. No radiomic feature was selected in any outer fold of the combined model. Areas under the receiver operating characteristic curve (AUCs) for baseline, trajectory-radiomics, and combined models were 0.812, 0.543, and 0.819, respectively. The combined-minus-baseline AUC difference was 0.0065 (p < 0.001), attributable to fold-specific regularization rather than radiomic information, and the combined model had a higher (worse) Brier score than the baseline model (0.196 vs. 0.189).
Conclusion
Tracked coordinates enabled region construction, but conventional trajectory radiomics provided no attributable or clinically meaningful incremental value over clinical/location data. Independent validation is required before clinical application.
Zitieren
APA
Zheng, Y., Wang, L., & Jin, G. (2026). Incremental value of needle-trajectory radiomics using publicly available three-dimensional transrectal ultrasound data for detecting core-level clinically significant prostate cancer. Eurasian Journal of Medicine and Oncology, 0(0), 026350451. https://doi.org/10.36922/ejmo026350451
Vancouver
Zheng Y, Wang L, Jin G. Incremental value of needle-trajectory radiomics using publicly available three-dimensional transrectal ultrasound data for detecting core-level clinically significant prostate cancer. Eurasian Journal of Medicine and Oncology. 2026;0(0):026350451. doi:10.36922/ejmo026350451
BibTeX
@article{Zheng2026,
author = {Zheng, Yongzhe and Wang, Lixin and Jin, Guangming},
title = {Incremental value of needle-trajectory radiomics using publicly available three-dimensional transrectal ultrasound data for detecting core-level clinically significant prostate cancer},
journal = {Eurasian Journal of Medicine and Oncology},
year = {2026},
volume = {0},
number = {0},
pages = {026350451},
doi = {10.36922/ejmo026350451}
}
EUVIMED